Abstract
The α-adrenergic mechanisms exert a stimulatory influence on the secretion of growth hormone (GH) in the rat. In the present study the α receptors involved in GH regulation were characterized with respect to subtype. It was also investigated whether the GH response to α receptor agonists can be utilized to assess changes in the responsiveness of central α receptors. The experiments were performed on rats with implanted intra-aortic cannulae allowing frequent blood sampling from freely moving animals. Plasma GH was determined by radioimmunoassay. Reserpine (10 mg/kg) caused a suppression of the normal pulsatile secretory pattern of GH. The α receptor agonist clonidine (CLON) given to reserpine-pretreated animals induced a dose-dependent increase in plasma GH. The effect of CLON (0.2 mg/kg) was prevented by pretreatment with the α2 receptor antagonist yohimbine (3 mg/kg), but not by the α1 receptor antagonist phenoxybenzamine (10 mg/kg). Chronic pretreatment with CLON or imipramine, either of which can be expected to produce a reduced sensitivity of central α2 receptors, resulted in reduced GH responses to CLON. On the other hand, chronic treatment with yohimbine, which should cause denervation supersensitivity of α2 receptors, led to enhanced GH responses to CLON. The results indicate that GH release in the rat is stimulated by postsynaptic α2 receptors. They also suggest that the GH response to CLON can be used as a valid in vivo model reflecting decreased, as well as increased responsiveness of this type of receptor.
Similar content being viewed by others
References
Andén NE (1967) Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system. Eur J Pharmacol 1:1–5
Andén NE, Corrodi H, Fuxe K, Hökfelt B, Hökfelt T, Rydin C, Svensson T (1970) Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci 9:513–523
Andén NE, Grabowska M, Strömbom U (1976) Different alpha-adrenoceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn Schmiedebergs Arch Pharmacol 292:43–52
Arnold MA, Fernstrom JD (1980) Administration of antisomatostatin serum to rats reverses the inhibition of pulsatile growth hormone secretion produced by injection of metergoline but not yohimbine. Neuroendocrinology 31:194–199
Baudry M, Martres MP, Schwartz JC (1976) Modulation in the sensitivity of noradrenergic receptors in the CNS studied by the responsiveness of the cyclic AMP system. Brain Res 116:111–124
Berthelsen S, Pettinger WA (1977) A functional basis for classification of α-adrenergic receptors. Life Sci 21:595–606
Checkley SA, Slade AP, Shur E (1981) Growth hormone and other responses to clonidine in patients with endogenous depression. Br J Psychiatry 138:51–55
Day TA, Willoughby JO (1980) Noradrenergic afferents to median eminence: Inhibitory role in rhythmic growth hormone secretion. Brain Res 202:335–345
Delini-Stula A, Baumann P, Büch O (1979) Depression of exploratory activity by clonidine in rats as a model for the detection of relative pre- and postsynaptic central noradrenergic receptor selectivity of α-adrenolytic drugs. Naunyn Schmiedebergs Arch Pharmacol 307:115–122
Doxey JC, Smith CFC, Walker JM (1977) Selectivity of blocking agents for pre- and postsynaptic α-adrenoceptors. Br J Pharmacol 60:91–96
Durand D, Martin JB, Brazeu P (1977) Evidence for a role of α-adrenergic mechanisms in regulation of episodic growth hormone secretion in the rat. Endocrinology 100:722–728
Edén S (1978) The secretory pattern of growth hormone. Acta Physiol Scand (Suppl) 458:12–20
Edén S, Bolle P, Modigh K (1979) Monoaminergic control of episodic growth hormone secretion in the rat: Effects of reserpine, α-methyl-p-tyrosine, p-chlorophenylalanine, and haloperidol. Endocrinology 105:523–529
Edén S, Eriksson E, Martin JB, Modigh K (1981) Evidence for a growth hormone-releasing factor mediating alpha-adrenergic influence on growth hormone secretion in the rat. Neuroendocrinology 33:24–27
Edén S, Modigh K (1977) Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks. Brain Res 129:379–384
Engberg G, Elam M, Svensson TH (1982) Clonidine withdrawal: Activation of brain noradrenergic neurons with specifically reduced α2 receptor sensitivity. Life Sci 30:235–243
Eriksson E, Edén S, Modigh K (1980) Enhanced growth hormone response to clonidine in the spontaneously hypertensive rat. Clin Exp Hypertension 2:341–346
Hansson L, Hunyor SN, Julius S, Hoobler SW (1973) Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Br Med J 2:209–213
Johnson RW, Reisine T, Spotnitz S, Wiech N, Ursillo R, Yamamura HI (1980) Effects of desipramine and yohimbine and α2- and β-adrenorreceptor sensitivity. Eur J Pharmacol 67:123–127
Kobinger W, Pichler L (1967) Centrally induced reduction in sympathetic tone: A postsynaptic α-adrenoceptor-stimulating action of imidazolines. Eur J Pharmacol 40:311–320
Lal S, Tolis G, Martin JB, Brown GM, Guyda H (1975) Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone, and thyroid-stimulating hormone in the serum of normal men. J Clin Endocrinol Metab 41:827–832
LeQuan-Bui KH, Elghozi JL, Devynck MA, Meyer P (1980) Early changes in noradrenaline content of some brain nuclei in spontaneously hypertensive rats. Clin Sci 59:243–246
Matussek N, Ackenheil M, Hippius H, Müller F, Scröder HT, Schultes H, Wasilewski B (1980) Effect of clonidine on growth hormone release in psychiatric patients and controls. Psychiatry Res 2:25–36
McMillen BA, Warnack W, German DC, Shore PA (1980) Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs. Eur J Pharmacol 61:239–246
Modigh K, Bolle P, Eden S (1979) Catecholaminergic control of growth hormone secretion in rats. In: Usdin E, Kopin IJ, Barchas J (eds) Catecholamines: Basic and clinical frontiers. Pergamon, New York, pp 1215–1217
Negro-Vilar A, Ojeda SR, Advis JP, McCann SM (1979) Evidence for noradrenergic involvement in episodic prolactin and growth hormone release in ovariectomized rats. Endocrinology 105:86–91
Rudolph CD, Kaplan SL, Ganong WF (1980) Sites at which clonidine acts to affect blood pressure and the secretion of renin, growth hormone and ACTH. Neuroendocrinology 31:121–128
Saavedra JM, Grobecker H, Axelrod J (1978) Changes in central catecholaminergic neurons in the spontaneously (genetic) hypertensive rat. Circ Res 42:529–534
Schwartz JC, Costentin J, Martres MP, Protais P, Baudry M (1978) Modulation of receptor mechanisms in the CNS: Hyper- and hyposensitivity to catecholamines. Neuropharmacology 17: 665–685
Smith CB, Carcia-Sevilla JA, Hollingsworth PJ (1981) 331-1 in rat brain are decreased after long-term tricyclic antidepressant drug treatment. Brain Res 210:413–418
Spyraki C, Fibiger HC (1980) Functional evidence for subsensitivity of noradrenergic α2 receptors after chronic desipramine treatment. Life Sci 27:1863–1867
Terry LC, Martin JB (1981) Evidence for α-adrenergic regulation of episodic growth hormone and prolactin secretion in the undisturbed male rat. Endocrinology 108:1869–1873
U'Prichard DC, Bechtel WD, Rouot BM, Snyder SH (1979) Multiple apparent alpha-noradrenergic receptor binding sites in rat brain: Effect of 6-hydroxydopamine. Mol Pharmacol 16:47–60
U'Prichard DC, Snyder SH (1978) 3H-catecholamien binding to α receptors in rat brain: Enhancement by reserpine. Eur J Pharmacol 51:145–155
Vaitukaitis J, Robbins JB, Nieschlag E, Ross GT (1971) A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab 33:988–991
Vetulani J, Stawarz RJ, Dingell JV, Sulser F (1976) A possible common mechanism of action of antidepressant treatments. Naunyn Schmiedebergs Arch Pharmacol 293:109–114
Willoughby JO, Day TA (1981) Central catecholamine depletion: Effects on physiological growth hormone and prolactin secretion. Neuroendocrinology 32:65–69
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Eriksson, E., Edén, S. & Modigh, K. Up- and down-regulation of central postsynaptic α2 receptors reflected in the growth hormone response to clonidine in reserpine-pretreated rats. Psychopharmacology 77, 327–331 (1982). https://doi.org/10.1007/BF00432764
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00432764